Article

Osteoarticular prosthetic infection: how many patients are eligible for phage therapy? A French single-centre retrospective study

2024-07-09

Abstract excerpt

<title>Abstract</title> <p><bold>Background.</bold> Bone and joint infections represent a major public health issue due to their increasing prevalence, their functional prognosis and their cost to society. Phage therapy has valuable anti-biofilm properties against prosthetic joint infections (PJI). The aim of this study was to establish the proportion of patients eligible for phage therapy and to assess their cli...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 919a8ec6-7889-5580-9bea-7f60fa12389e
DOI: 10.21203/rs.3.rs-4590485/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Osteoarticular prosthetic infection: how many patients are eligible for phage therapy? A French single-centre retrospective studyDOI 10.21203/rs.3.rs-4590485/v1Read

Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint InfectionSemantic proximity Read

Bacteriophage Application for Difficult-To-Treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment ProtocolSemantic proximity Read

Processing Phage Therapy Requests in a Brussels Military Hospital: Lessons IdentifiedSemantic proximity Read

First Use of Phage Therapy in Canada for the Treatment of a Life-Threatening, Multidrug-Resistant Staphylococcus epidermidis Periprosthetic Joint InfectionSemantic proximity Read

Bacteriophage therapy created the necessary conditions for successful antibiotic suppression in a periprosthetic hip joint infection: a Case ReportSemantic proximity Read

Analysis of phage therapy failure in a patient with a<i>Pseudomonas aeruginosa</i>prosthetic vascular graft infectionSemantic proximity Read

Bacteriophage therapy for periprosthetic joint infections: Current limitations and research needed to advance this therapeuticSemantic proximity Read

Drug treatments for prosthetic joint infections in the era of multidrug resistanceSemantic proximity Read

What’s New in Musculoskeletal Infection: Update on BiofilmsSemantic proximity Read

Phage Activity against Planktonic and Biofilm Staphylococcus aureus Periprosthetic Joint Infection IsolatesSemantic proximity Read

Antibiotic Prophylaxis in Total Joint ArthroplastySemantic proximity Read

Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?Semantic proximity Read